KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Equity (2020 - 2025)

Historic Return on Equity for Royalty Pharma (RPRX) over the last 6 years, with Q3 2025 value amounting to 0.14%.

  • Royalty Pharma's Return on Equity fell 400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.13% for FY2024, which is 400.0% down from last year.
  • Royalty Pharma's Return on Equity amounted to 0.14% in Q3 2025, which was down 400.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Return on Equity ranged from a high of 0.19% in Q2 2021 and a low of 0.02% during Q4 2022
  • Its 5-year average for Return on Equity is 0.12%, with a median of 0.12% in 2021.
  • As far as peak fluctuations go, Royalty Pharma's Return on Equity plummeted by -1500bps in 2021, and later soared by 1500bps in 2023.
  • Quarter analysis of 5 years shows Royalty Pharma's Return on Equity stood at 0.12% in 2021, then plummeted by -81bps to 0.02% in 2022, then surged by 649bps to 0.17% in 2023, then decreased by -25bps to 0.13% in 2024, then increased by 5bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q3 2025, compared to 0.17% in Q2 2025 and 0.18% in Q1 2025.